Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

QXO, Inc. (QXO) Reports Q1 Loss, Beats Revenue Estimates
QXO, Inc. (QXO) Reports Q1 Loss, Beats Revenue Estimates

QXO, Inc. (QXO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.03 per share a year ago. These figures are

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.49 per share a year ago

Nextracker (NXT) Surpasses Q4 Earnings and Revenue Estimates
Nextracker (NXT) Surpasses Q4 Earnings and Revenue Estimates

Nextracker (NXT) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $1.29 per share a year ago. These figures

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

NeuroPace, Inc. (NPCE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.21 per share a year ago. These figures

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.12 per share a year ago. These figures are adjusted

Hyliion Holdings Corp. (HYLN) Reports Q1 Loss, Tops Revenue Estimates
Hyliion Holdings Corp. (HYLN) Reports Q1 Loss, Tops Revenue Estimates

Hyliion Holdings Corp. (HYLN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.1 per share a year ago. These

KLX Energy Services (KLXE) Reports Q1 Loss, Lags Revenue Estimates
KLX Energy Services (KLXE) Reports Q1 Loss, Lags Revenue Estimates

KLX Energy Services (KLXE) came out with a quarterly loss of $1.18 per share versus the Zacks Consensus Estimate of a loss of $1.27. This compares to a loss of $1.27 per share a year ago. These

Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Beats Revenue Estimates
Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Beats Revenue Estimates

Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.09 per share a year ago. These

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.1 per share a year ago. These figures are

Evolv Technologies Holdings, Inc. (EVLV) Reports Q1 Loss, Beats Revenue Estimates
Evolv Technologies Holdings, Inc. (EVLV) Reports Q1 Loss, Beats Revenue Estimates

Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.01 per share a year

Fold Holdings, Inc. (FLD) Reports Q1 Loss, Lags Revenue Estimates
Fold Holdings, Inc. (FLD) Reports Q1 Loss, Lags Revenue Estimates

Fold Holdings, Inc. (FLD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.42 per share a year ago. These

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.31 per share versus the Zacks Consensus Estimate of a loss of $2.85. This compares to a loss of $5.8 per share a year ago

GrowGeneration (GRWG) Reports Q1 Loss, Beats Revenue Estimates
GrowGeneration (GRWG) Reports Q1 Loss, Beats Revenue Estimates

GrowGeneration (GRWG) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.16 per share a year ago. These figures

HireQuest, Inc. (HQI) Q1 Earnings and Revenues Beat Estimates
HireQuest, Inc. (HQI) Q1 Earnings and Revenues Beat Estimates

HireQuest, Inc. (HQI) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.1 per share a year ago. These

Arteris, Inc. (AIP) Reports Q1 Loss, Beats Revenue Estimates
Arteris, Inc. (AIP) Reports Q1 Loss, Beats Revenue Estimates

Arteris, Inc. (AIP) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.09 per share a year ago. These figures are

Astronics Corporation (ATRO) Q1 Earnings and Revenues Top Estimates
Astronics Corporation (ATRO) Q1 Earnings and Revenues Top Estimates

Astronics Corporation (ATRO) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.44 per share a year ago

The Beachbody Company, Inc. (BODI) Tops Q1 Earnings and Revenue Estimates
The Beachbody Company, Inc. (BODI) Tops Q1 Earnings and Revenue Estimates

The Beachbody Company, Inc. (BODI) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.84 per share

Mobile Infrastructure Corporation (BEEP) Reports Q1 Loss, Misses Revenue Estimates
Mobile Infrastructure Corporation (BEEP) Reports Q1 Loss, Misses Revenue Estimates

Mobile Infrastructure Corporation (BEEP) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.1 per share a year

AudioEye (AEYE) Q1 Earnings Miss Estimates
AudioEye (AEYE) Q1 Earnings Miss Estimates

AudioEye (AEYE) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.15 per share a year ago. These figures

Black Rock Coffee Bar, Inc. (BRCB) Reports Q1 Earnings: What Key Metrics Have to Say
Black Rock Coffee Bar, Inc. (BRCB) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2026, Black Rock Coffee Bar, Inc. (BRCB) reported revenue of $55.45 million, representing no change compared to the same period last year. EPS came in at $0.02, compared

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.33 per share a year ago

OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.08 per share a year ago. These

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Verrica Pharmaceuticals Inc. (VRCA) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $1 per share a year ago

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.25 per share a year ago. These figures

QuickLogic (QUIK) Reports Q1 Loss, Lags Revenue Estimates
QuickLogic (QUIK) Reports Q1 Loss, Lags Revenue Estimates

QuickLogic (QUIK) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.07 per share a year ago. These figures are